CoChat

Interleukin 18 and coronary heart disease: Prospective study and systematic review

Open access
Jefferis, Barbara J.M.H., Papacosta, Olia, Owen, Christopher G., Wannamethee, S. Goya, Humphries, Steve E., Woodward, Mark, Lennon, Lucy T., Thomson, Andrew, Welsh, Paul, Rumley, Ann, Lowe, Gordon D.O., Whincup, Peter H. · 2011 · Atherosclerosis
Cited by 123

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

AIM: Previous studies suggest that circulating levels of interleukin-18 (IL-18) may be prospectively related to risk of coronary heart disease (CHD) in the general population. We report new data from the largest prospective study to date, which are combined with data from all published prospective studies in a meta-analysis. METHODS: We measured baseline IL-18 levels in stored serum samples of subjects from a case-control study nested within a prospective study of 5661 men aged 40-59 years recruited from general practices in 18 British towns in 1978-1980 and followed-up for up to 16 years (median time to event 8.4 years) for fatal CHD and non-fatal myocardial infarction (595 cases, 1238 controls). RESULTS: IL-18 concentrations were strongly related to cigarette smoking, triglyceride, HDL-cholesterol (inversely) and to circulating levels of several inflammatory and haemostatic markers. Men in the top third of baseline IL-18 levels had an age-adjusted odds ratio (OR) for CHD of 1.55 (95% CI 1.21, 1.98) compared with those in the lowest third; this was reduced to 1.30 (95% CI 0.99, 1.69) after additional adjustment for vascular risk factors and 1.12 (95% CI 0.84, 1.49) after further adjustment for CRP and IL-6. In meta-analyses of CVD, associations (or effect sizes) were consistent between studies; RRs were 1.64 [corrected] (95% CI 1.48, 1.83) [corrected] after age adjustment, 1.39 (95% CI 1.25, [corrected] 1.55) after additional risk factor adjustment and 1.34 (95% CI 1.17, 1.53) [corrected] after additional adjustment for inflammatory markers. CONCLUSIONS: Circulating IL-18 is prospectively and independently associated with CVD risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2011.03.015

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 123

Metadata

Authors
Jefferis, B. J. M. H., Papacosta, O., Owen, C. G., Wannamethee, S. G., Humphries, S. E., Woodward, M., Lennon, L. T., Thomson, A., Welsh, P., Rumley, A., Lowe, G. D. O., & Whincup, P. H.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2011-07
Volume
217
Issue
1
Pages
227-233
ISSN
0021-9150 (ISSN-L)
OpenAlex
W2097502821
Cited by
123
References
3
FWCI
0.49
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin 18 and coronary heart disease: Prospective study and systematic review. https://app.cochat.ai/papers/10.1016/j.atherosclerosis.2011.03.015
The paper
Jefferis, B. J. M. H., Papacosta, O., Owen, C. G., Wannamethee, S. G., Humphries, S. E., Woodward, M., Lennon, L. T., Thomson, A., Welsh, P., Rumley, A., Lowe, G. D. O., & Whincup, P. H. (2011). Interleukin 18 and coronary heart disease: Prospective study and systematic review. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2011.03.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.